We have located links that may give you full text access.
Segmental phenolic ablation for ingrown toenails in general practice.
Irish Medical Journal 2000 November
Ingrown toenails cause a great deal of discomfort and may result in missed time from school, work and sports. Traditionally, this problem was quickly dealt with by a simple nail avulsion or wedge avulsion in general practice, Accident and Emergency departments or O.P.D.s. However, this treatment has a high relapse rate (73%). In this survey ingrown toenails were treated by wedge resection and ablation of the nail bed with 80% fresh phenol under ring block anaesthesia and a bloodless field. The aim of this prospective study was to assess the feasibility, cure rate and complications of Segmental Phenolic Ablation for ingrown toenails in general practice. A prospective analysis of 201 consecutive Wedge Resections and Phenol Ablations for ingrown toenails in 111 patients by one General Practitioner over a five and a half year period. All patients were followed up for at least six months post-operatively. There was a relapse rate of 4.5%. Two-thirds of the recurrences occurred in patients who had relapsed after previous surgery before entering this study. All recurrences were successfully treated by repeat phenol cauterisation. The relapse rate for cases who had never been previously operated on (137 edges) was 2.2% (3 edges). There were no major peri-operative or post-operative complications. No patient had to be referred to hospital for treatment of their ingrown toenails. Wedge Resection and Phenol Ablation for ingrown toenails can be carried out safely and successfully in general practice and is recommended as the surgical treatment of choice.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app